One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement during Initial Assessment and Treatment in Emergency Care] Trial)

Harry P. Selker, James E. Udelson, Joseph M. Massaro, Robin Ruthazer, Ralph B. D'Agostino, John L. Griffith, Patricia R. Sheehan, Patrice Desvigne-Nickens, Yves Rosenberg, Xin Tian, Ellen M. Vickery, James M Atkins, Tom P. Aufderheide, Assaad J. Sayah, Ronald G. Pirrallo, Michael K. Levy, Michael E. Richards, Darren A. Braude, Delanor D. Doyle, Ralph J. FrasconeDonald J. Kosiak, James M. Leaming, Carin M. Van Gelder, Gert Paul Walter, Marvin A. Wayne, Robert H. Woolard, Joni R. Beshansky

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement during Initial Assessment and Treatment in Emergency Care] Trial)'. Together they form a unique fingerprint.

One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement during Initial Assessment and Treatment in Emergency Care] Trial)

Fingerprint

Medicine & Life Sciences